SynthesisFrontiers in immunology2026

PD-1/PD-L1 inhibitors plus chemotherapy as first-line therapy for advanced or metastatic endometrial cancer: a systematic review and meta-analysis of randomized controlled trials.

Zhilong Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.